ACTSI Investigator Dr. Peter Wilson in the News

Peter Wilson, MD, ACTSI investigator, professor of Medicine and Public Health, Emory University, and Director of Epidemiology and Genomic Medicine, Atlanta VA Medical Center

Atlanta Journal-Constitution | Advil, Aleve, Motrin, more can cause heart attack or stroke: FDA
July 16, 2015

New York Times | Experts urge sparing use of nonaspirin painkillers
July 13, 2015

The New York Times | Federal panel backs approval of new drug to fight heart attacks
June 9, 2015

Wilson joined more than 3,000 researchers on a Thomson Reuters searchable list of "Highly Cited Researchers 2014" that identifies researchers worldwide who wrote the greatest numbers of highly cited papers over the past decade in 21 fields. These researchers ranked in the top 1% most cited for their subject field and year of publication, "earning them the mark of exceptional impact.” Read more…

#emorymedicine | Investing in Our Future
December 2, 2014

Bloomberg News | Amarin's fish oil pill fails to win US panel's backing
October 16, 2013

Reuters | Update 1 - Multivitamins don't cut heart disease risk in men – study
November 5, 2012

Recent Publications:
“Clinician-Patient Risk Discussion for Atherosclerotic Cardiovascular Disease Prevention: Importance to Implementation of the 2013 ACC/AHA Guidelines.” J Am Coll Cardiol. 2015 Apr 7;65(13):1361-1368.  Read more…

“Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.S.” J Gen Intern Med. 2015 Jun;30(6):749-57. Read more…

Upcoming Events

View All Events

Latest News

Training

ACTSI-supported OculoStaple Wins Again

Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...

Discovery

Infographic: What are the Phases of Clinical Trials?